Solomkin JS, Yellin AE, Rotstein OD et al. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: Results of a double-blind, randomized comparative phase III trial. Ann Surg 2002;237(2):235–245.
Yellin AE, Hassett JM, Fernandez A et al for the 004 Intraabdominal Infection Study Group. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. Int J Antimicrob Agents 2002;20:165–173.
Dorso KL, Woods G, Friedland I et al. In vitro kill rates of ertapenem, ceftriaxone (CRO) and piperacillin/tazobactam (pip/taz) against intra-abdominal pathogens. American Society of Microbiology, Salt Lake City, Utah, USA, May 19-24, 2002 [poster A-156].
Mazuski JE, Sawyer RG, Nathens AB et al for the Therapeutic Agents Committee of the Surgical Infection Society. The Surgical Infection Society Guidelines on antimicrobial therapy for intra-abdominal infections: Evidence for the recommendations. Surg Infect 2002;3(3):175–233.
